PREDICT-DM: Community Pharmacy-Based Point-of-Care Testing for Undiagnosed T2DM

The goal of this observational study is to learn whether community pharmacy-based risk assessment and point-of-care HbA1c testing can help detect undiagnosed type 2 diabetes and prediabetes among adults in Irbid Governorate, Jordan, who have no previous diabetes diagnosis. The main questions it aims to answer are: What proportion of participants fall into each Finnish Diabetes Risk Score category? What proportion of participants at high or very high risk have HbA1c results within the prediabetes or diabetes range? Participants will: Complete the Finnish Diabetes Risk Score questionnaire at a community pharmacy. Receive a finger-prick HbA1c test at the pharmacy if their risk score is 15 or higher. Visit a general practitioner or primary care facility for diagnostic confirmation if their HbA1c result is abnormal. Attend follow-up assessments at three and six months if a general practitioner confirms type 2 diabetes.